机构:[1]Department of Gastroenterology, Shanghai Key Laboratory of Pancreatic Diseases, Shanghai General Hospital, Nanjing Medical University, Shanghai, China[2]Center for Biomarker Discovery and Validation, National Infrastructures for Translational Medicine (PUMCH), Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China[3]State Key Laboratory of Complex, Severe, and Rare Diseases, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China[4]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China外科系统普通外科首都医科大学宣武医院
National Natural Science Foundation of China (82122010 and 82070659 to Li Wen), Shanghai Natural
Science Foundation (22ZR1480500 to Li Wen), National High Level
Hospital Clinical Research Funding (2022-PUMCH-E-003 to Li Wen)
and CAMS Innovation Fund for Medical Sciences (2023-I2M-3-001
to Li Wen and 2022-I2M-1-004).
第一作者机构:[1]Department of Gastroenterology, Shanghai Key Laboratory of Pancreatic Diseases, Shanghai General Hospital, Nanjing Medical University, Shanghai, China
共同第一作者:
通讯作者:
通讯机构:[2]Center for Biomarker Discovery and Validation, National Infrastructures for Translational Medicine (PUMCH), Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China[3]State Key Laboratory of Complex, Severe, and Rare Diseases, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
Huang Huizhen,Lu Wanyi,Zhang Xiuli,et al.Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies[J].CELLULAR ONCOLOGY.2024,47(2):383-396.doi:10.1007/s13402-023-00874-x.
APA:
Huang Huizhen,Lu Wanyi,Zhang Xiuli,Pan Jiachun,Cao Feng&Wen Li.(2024).Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies.CELLULAR ONCOLOGY,47,(2)
MLA:
Huang Huizhen,et al."Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies".CELLULAR ONCOLOGY 47..2(2024):383-396